Labcorp to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
Labcorp (NYSE: LH) will announce its fourth quarter and full year 2020 financial results on Feb. 11, 2021, prior to market opening. A conference call will follow at 9:00 a.m. ET to discuss the results. Last year, Labcorp reported revenues of $11.5 billion. The investor relations website will provide the earnings release and additional information. An audio replay of the call will be available until Feb. 25, 2021. The company advises stakeholders to consider forward-looking statements cautiously due to various market risks.
- Reported revenue of $11.5 billion in FY2019.
- Uncertainty regarding the impact of COVID-19 on business and financial condition.
- Risks related to competitive actions and unforeseen market changes.
- Potential adverse effects from regulatory changes and customer purchasing decisions.
Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, Feb. 11, 2021, and then will host a conference call and webcast beginning at 9:00 a.m. ET to discuss the results. The earnings release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Interested parties can access the conference call by dialing 1-877-898-8036 within the U.S. and Canada, or 1-720-634-2811 internationally, using the conference ID 7378794. In addition, a real-time webcast of the conference call will be available on the Labcorp Investor Relations website.
An audio replay of the conference call will be available from 1:00 p.m. ET on Feb. 11, 2021, until 11:30 p.m. ET on Feb. 25, 2021, by dialing 1-855-859-2056 within the U.S. and Canada, or 1-404-537-3406 internationally, using the conference ID 7378794. The webcast of the conference call will be archived and accessible through Jan. 28, 2022, on the Labcorp Investor Relations website.
About Labcorp
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and save lives. With over 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including but not limited to statements with respect to the impact of various factors on operating and financial results and the opportunities for future growth. Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the Company’s control, including without limitation, the impact of the COVID-19 pandemic on our business and financial condition as well as on general economic, business, and market conditions, competitive actions and other unforeseen changes and general uncertainties in the marketplace, changes in government regulations, including healthcare reform, customer purchasing decisions, including changes in payer regulations or policies, other adverse actions of governmental and third-party payers, the Company’s satisfaction of regulatory and other requirements, patient safety issues, changes in testing guidelines or recommendations, federal, state, and local governmental responses to the COVID-19 pandemic, adverse results in material litigation matters, failure to maintain or develop customer relationships, our ability to develop or acquire new products and adapt to technological changes, failure in information technology, systems or data security, changes in business conditions and the economy in general, adverse weather conditions, the number of revenue days in a financial period, employee relations, personnel costs, and effect of exchange rate fluctuations. These factors, in some cases, have affected and in the future (together with other factors) could affect the Company’s ability to implement the Company’s business strategy and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the Company’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the Company’s other filings with the SEC.
###
View source version on businesswire.com: https://www.businesswire.com/news/home/20210108005244/en/
FAQ
When will Labcorp release its 2020 financial results?
What was Labcorp's revenue for FY2019?
How can I access Labcorp's financial results conference call?
What is the conference ID for Labcorp's financial results call?
How long will the audio replay of Labcorp's conference call be available?
